Cu(II) is held in a square-planar coordination sphere by the N-terminal amine, the deprotonated glycyl amide nitrogen and the histidine imidazole, at a stability constant (log K approximately 16.4) close to that of the copper transport site on human serum albumin
How Cagrilintide Compares to Other Metabolic Peptides Comparing cagrilintide to the metabolic peptide categories already in research circulation: The key distinction: cagrilintide is not a GLP-1 axis compound at all
The FDA identifies significant risks including lack of human safety data, potential for adverse immune reactions, and insufficient evidence regarding long-term effects, with the agency authorized to take enforcement action against compounding pharmacies that produce these substances for clinical applications
This specific sequence was first isolated from human plasma in the 1970s, making it a naturally occurring compound that the body already recognizes and utilizes
Copper peptides show particular promise for androgenetic alopecia
Because phosphate groups are introduced only after peptide assembly is complete, this approach eliminates the need for pre-phosphorylated amino acid building blocks and circumvents the reduced coupling efficiency associated with the steric bulk and diminished nucleophilicity of protected phosphoamino acids